Financhill
Back

Profound Medical Quote, Financials, Valuation and Earnings

Profound Medical Price Quote

$7.51
+0.08 (+-0.53%)
(Updated: December 13, 2024 at 5:48 AM ET)

Profound Medical Key Stats

Sell
33
Profound Medical (PROF) is a Sell

Day range:
$7.05 - $7.70
52-week range:
$7.05 - $11.42
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
19.54
P/B ratio:
7.18%

Volume:
85.8K
Avg. volume:
82.6K
1-year change:
-27.93%
Market cap:
$223.1M
Revenue:
$7.2M
EPS:
$-1.34

How Much Does Profound Medical Make?

Is Profound Medical Growing As A Company?

  • What Is Profound Medical's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.64%
  • What Is Profound Medical's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Profound Medical Stock Price Performance

  • Did Profound Medical Stock Go Up Last Month?
    Profound Medical share price went down by -6.66% last month
  • Did PROF's Share Price Rise Over The Last Year?
    PROF share price fell by -27.93% over the past 1 year

What Is Profound Medical 52-Week High & Low?

Profound Medical Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Profound Medical?

  • How Much Debt Does Profound Medical Have?
    Total long term debt quarterly is $5.6M
  • How Much Cash Does Profound Medical Have?
    Cash and short term investments quarterly total is $27.1M
  • What Is Profound Medical’s Book Value Per Share?
    Book value per share is 1.26

Is Profound Medical Cash Flow Positive?

  • What Is PROF Cash Flow From Operations?
    Cash flow from operations (TTM) is -$24.8M
  • What Is Profound Medical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $18.6M
  • What Is Profound Medical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Profound Medical Return On Invested Capital

  • Is Management Doing A Good Job?
    PROF return on invested capital is -71.9%
  • What Is Profound Medical Return On Assets?
    ROA measures how assets are converting to revenues and is -64.33%
  • What Is PROF Return On Equity?
    ROE is a measure of profitability and is -84.43%

Profound Medical Earnings Date & Stock Price

Profound Medical Competitors

  • Who Are Profound Medical's Competitors?
    Below is a list of companies who compete with Profound Medical or are related in some way:
    • CytoSorbents Corp (CTSO)
    • Delcath Systems Inc (DCTH)
    • Exact Sciences Corp (EXAS)
    • Progyny Inc (PGNY)
    • Star Equity Holdings Inc (STRR)

Profound Medical Dividend Yield

Profound Medical Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -25.62%
Revenue: 63.89% -6.02%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 15.30
Upside from Last Price: 105.92%

Major Shareholders

  • How many PROF shares are owned by institutional investors?
    12.1M PROF shares are owned by institutional investors
  • How many PROF shares are owned by insiders?
    0 PROF shares are owned by insiders